key: cord-0863697-lidqhd26 authors: Tang, Feng; Luo, Wanjun; Wang, Xiaowen; Li, Hui; Mei, Hong; Shao, Jianbo; Song, Qifa title: Clinical features and follow‐up of pediatric patients hospitalized for COVID‐19 date: 2021-04-14 journal: Pediatr Pulmonol DOI: 10.1002/ppul.25407 sha: 9d27ed31d661d7a9d221810c525a9273b18b6d8f doc_id: 863697 cord_uid: lidqhd26 OBJECTIVE: This report summarizes the clinical features and 1‐month follow‐up observations for pediatric patients who were hospitalized with coronavirus disease 2019 (COVID‐19) in Wuhan Women and Children's Hospital. METHODS: The 1‐month follow‐up data included clinical manifestations and results from serum severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) IgG and IgM tests, reverse‐transcription polymerase chain reaction (RT‐PCR) for SARS‐CoV‐2, lung computed tomography (CT) scans, and laboratory tests. RESULTS: Between January 20 and March 15, 2020, 127 patients aged 0–15 years were hospitalized for COVID‐19 treatment, including 3 severe cases and 124 mild or moderate cases. The main therapies included inhalation of aerosolized interferon‐α (122/127) and additional antiviral drugs (28/127). Among the 81 patients who had pneumonia at admission, 35 with right lobe pneumonia had the longest hospital stay (mean 14.5 ± 7 days); 17 with left lobe pneumonia had the highest creatine kinase (154 ± 106 U/L) and creatine kinase myocardial band (CK‐MB, 43 ± 48 U/L) levels; and 29 with bilateral pneumonia had the highest white blood cell counts (8.3 ± 4 × 10(9)/L). Among the 46 patients who were successfully followed up 1 month after discharge, two notable findings were right lobe pneumonia in 22% (95% confidence interval [CI]: 11%–37%) of patients and persistently elevated serum creatine kinase and CK‐MB levels. The median duration of elevated CK‐MB was 45 days. The mean concentrations of serum SARS‐CoV‐2 IgG and IgM in 41 patients were 8.0 ± 7.5 and 98 ± 40 ng/ml, respectively. At follow‐up, four patients retested positive for SARS‐CoV‐2. CONCLUSIONS: The involvement of different lung lobes in patients with COVID‐19 was associated with variations in the persistence of pneumonia and elevation of CK‐MB levels and body temperature. In December 2019, the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was identified as the pathogen responsible for a series of infections typical of pneumonia in the city of Wuhan in China. 1 This infectious disease soon became a global pandemic given the name coronavirus disease 2019 (COVID-19) by the World Health Organization (WHO). By March 9, 2021 , the WHO had reported 116 million cases and 2.6 million deaths due to COVID-19 worldwide. 2 A cohort study of 44,672 Chinese cases reported that 2.1% of patients were aged <20 years. 3 It is well established now that COVID-19 can cause damage to several vital organs, including the lungs, heart, liver, and kidney, 4 generating a variety of complex clinical features. Compared with the clinical features and treatment outcomes observed in adult COVID-19 patients, pediatric patients with COVID- 19 have presented with milder clinical manifestations. 5 In the early stage of the pandemic, pediatric patients were sometimes treated with aerosolized interferon-α and sometimes with lopinavir/ritonavir syrup, and most recovered within 1 month of COVID-19 diagnosis. 5 However, a few patients who were clinically cured later tested positive for SARS-CoV-2 again. 6 These findings complicate the assessment of treatment outcomes and highlight the importance of a comprehensive follow-up. The pathogenic mechanisms of SARS-CoV-2 infection are analogous to those for the first SARS virus (SARS-CoV-1) because the viruses use the same receptors for cell entry. Thus, it is expected that SARS-CoV-2 infection may lead to long-term adverse outcomes as seen in SARS patients. 4 As distinct immunological responses to SARS-CoV-2 infection may exist in pediatric patients and result in damage to vital organs, 7 a follow-up of pediatric patients is necessary. 8 This study aimed to analyze outcomes in pediatric patients hospitalized at Wuhan Women and Children's Hospital based on a 1-month follow-up after discharge. The following characteristics of pediatric COVID-19 cases at the 1-month follow-up were examined: (1) detection of SARS-CoV-2 by reverse-transcription (RT)polymerase chain reaction (PCR); (2) clinical features, including symptoms and laboratory indices reflecting dysfunction of vital organs; and (3) differential outcomes in patients with different presentations on computed tomography (CT) scans. pneumonia. Follow-up was performed after the patients were clinically cured according to the following criteria 9 : fever-free for 3 consecutive days, improvement in pneumonia in terms of CT scans and upper respiratory manifestations, and two 3-day-interval consecutive negative RT-PCR results for SARS-CoV-2. The sample collection, RT-PCR conditions, and results interpretation were conducted as previously described. 10 Patients had nonenhanced chest CT examinations for pneumonia using a Siemens SOMATOM Definition AS128 instrument (Siemens Healthineers). CT features considered abnormal included cavitation, lymphadenopathy, pleural effusion consolidation, lesion, and infiltration suggestive of infection, as well as increased lung markings. CT scanning results were classified as no evidence of abnormality, increased lung markings, left and right lobe pneumonia, or bilateral pneumonia. On admission, all cases were classified as mild, moderate, severe, or critically ill cases according to the guidelines for scoring pediatric patients with COVID-19. 11 Briefly, in addition to a positive RT-PCR test for SARS-CoV-2 for all cases, mild cases presented with or without upper respiratory symptoms and no abnormal radiographic presentation; moderate cases had additional mild pneumonia; severe and critical cases presented with manifestations suggesting injury to vital organs and rapid disease progression. 5 The treatment included control of high fever, antiviral therapy, oxygen therapy as needed for hypoxia, and antibiotic therapy if a bacterial infection was suspected. The antiviral therapy involved inhalation of aerosolized interferon-α two times per day as well as anti-influenza drugs such as Abidor and Oseltamivir, as required. The data of patients at admission and after 1-month follow-up were retrospectively collected from electronic medical records and included demographic data, exposure history, underlying comorbidities, symptoms, laboratory examination results, CT scans, and therapy details. The laboratory examinations included immunological tests (C-reactive protein) as well as the measurement of biomarkers for liver function (alanine aminotransferase, aspartate transferase), myocardial function (creatine kinase myocardial band isoenzyme [CK-MB], creatine kinase, lactate dehydrogenase, and lactate dehydrogenase isoenzyme-1), and renal function (creatinine and blood urea nitrogen). At approximately 1 month after discharge, the following patient Data for continuous variables were described as mean and standard deviation (SD) and were compared between groups by independent group two-tailed t tests when values were normally distributed; otherwise, the Mann-Whitney U test was used. Data for categorical variables were described as number and percentage (%) and were compared between groups by Fisher's exact test. A two-sided α less than .05 was considered statistically significant. We defined elevated CK-MB as the initial event and normal CK-MB as the corresponding failure event. We compared the median duration of CK-MB elevation by Kaplan-Meier survival analysis to assess the treatment effect in different groups of patients. All data analyses were conducted using the R package (version 3.6). T A B L E 1 Demographic and clinical characteristics at admission for all included pediatric patients and pediatric patients who completed the 1-month follow-up examination reflecting immune responses and liver and renal damage showed a low prevalence both at admission and at follow-up, including elevation of alanine aminotransferase (n = 6 at admission), aspartate transferase (n = 6 at admission), creatinine (n = 0), blood urea nitrogen (n = 0), C-response protein (n = 2 at admission), and white blood cells (above 10 × 10 9 /L, n = 6 at admission) ( Table 3) . are potentially a useful marker for early identification and severity assessment. 16 Among the 46 patients who were successfully followed up 1 month after discharge, the prevalence of two common symptoms, dry cough and fever, decreased to 2% (Table 3) . From the follow-up laboratory tests, notable findings included elevation of creatine kinase, CK-MB, lactate dehydrogenase, and lactate dehydrogenase isoenzyme-1 levels above normal ranges in most patients (Figure 2 ). This phenomenon was different from other clinical features, which no longer showed abnormality at the 1-month follow-up (Table 3 ). Survival analysis demonstrated that 50% of the patients had patients. 19, 20 Notably, in children with COVID-19, cardiac involvement has been linked to an abnormal inflammatory response. 21 Our findings of persistently elevated CK-MB levels are consistent with the previous hypothesis that the heart is a primary target of injury in the multisystem inflammatory syndrome in children. 22 The duration of elevated CK-MB for up to 45 days is very close to the 1-month time course of multisystem inflammatory syndrome. 23 25 and viral myocarditis as a complication of acute upper respiratory tract infection. 26 We speculate a similar situation may exist in COVID-19, although more evidence is required to draw a sound conclusion. Other laboratory indices reflecting the immune response and liver and renal damage, including C-reactive protein, alanine aminotransferase, aspartate transferase, creatinine, and blood urea nitrogen, showed a low prevalence of abnormality both at admission and at the 1-month follow-up (Table 3) . Serum IgG and IgM against SARS-CoV-2 were de- The authors declare that there are no conflict of interests. writing review and editing (equal). The data that support the findings of this study are available on request from the corresponding author. The data are not publicly available due to privacy or ethical restrictions. Qifa Song http://orcid.org/0000-0001-9753-2924 Real-time tentative assessment of the epidemiological characteristics of novel coronavirus infections in Wuhan, China, as at 22 Novel Coronavirus Pneumonia Emergency Response Epidemiology Team. The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China Blood molecular markers associated with COVID-19 immunopathology and multi-organ damage Clinical and epidemiological features of 36 children with coronavirus disease 2019 (COVID-19) in Zhejiang, China: an observational cohort study The issue of recurrently positive patients who recovered from COVID-19 according to the current discharge criteria: investigation of patients from multiple medical institutions in Wuhan Children and COVID-19: microbiological and immunological insights Long-term consequences of COVID-19: research needs National Health and Health Commission of the people's Republic of China. Diagnosis and treatment guidelines for 2019 novel coronavirus pneumonia Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan Diagnosis and treatment recommendation for pediatric coronavirus disease-19. Zhejiang Da Xue Xue Bao Yi Xue Ban National Health and Health Commission of the people's Republic of China. Guidelines on diagnosis and treatment of novel coronavirus pneumonia Sensitivity of chest CT for COVID-19: comparison to RT-PCR Chest computed tomography and lung ultrasound findings in COVID-19 pneumonia: a pocket review for non-radiologists Toward a clinically based classification of disease severity for paediatric COVID-19-Authors' reply Pediatric lung imaging features of COVID-19: a systematic review and meta-analysis Redefining cardiac biomarkers in predicting mortality of Inpatients with COVID-19 Creatine kinase MB isoforms in patients with skeletal muscle injury: ramifications for early detection of acute myocardial infarction Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China Coronavirus fulminant myocarditis saved with glucocorticoid and human immunoglobulin COVID-19 in children and young people COVID-19 and multisystem inflammatory syndrome in children and adolescents COVID-19 and multisystem inflammatory syndrome in children: a systematic review and meta-analysis Transient cardiac injury during H7N9 infection Interrelationship of rotavirus infection and Creatine Kinase-MB isoenzyme levels in children hospitalized with acute gastroenteritis in Guangzhou Influenza-related viral myocarditis Clinical features and follow-up of pediatric patients hospitalized for COVID-19